Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Intraperitoneal delivery of paclitaxel by poly(ether-anhydride) microspheres effectively suppresses tumor growth in a murine metastatic ovarian cancer model.

Yang M, Yu T, Wood J, Wang YY, Tang BC, Zeng Q, Simons BW, Fu J, Chuang CM, Lai SK, Wu TC, Hung CF, Hanes J.

Drug Deliv Transl Res. 2014 Apr 1;4(2):203-9. doi: 10.1007/s13346-013-0190-7.

2.

Thermosensitive poly-(d,l-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(d,l-lactide-co-glycolide) hydrogels for multi-drug delivery.

Cho H, Kwon GS.

J Drug Target. 2014 Aug;22(7):669-77. doi: 10.3109/1061186X.2014.931406. Epub 2014 Jun 25.

3.

Galactose-decorated cross-linked biodegradable poly(ethylene glycol)-b-poly(ε-caprolactone) block copolymer micelles for enhanced hepatoma-targeting delivery of paclitaxel.

Yang R, Meng F, Ma S, Huang F, Liu H, Zhong Z.

Biomacromolecules. 2011 Aug 8;12(8):3047-55. doi: 10.1021/bm2006856. Epub 2011 Jul 14.

PMID:
21726090
4.
5.

Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.

Danhier F, Magotteaux N, Ucakar B, Lecouturier N, Brewster M, Préat V.

Eur J Pharm Biopharm. 2009 Oct;73(2):230-8. doi: 10.1016/j.ejpb.2009.06.015. Epub 2009 Jul 3.

PMID:
19577643
6.

A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer.

Xiao K, Luo J, Fowler WL, Li Y, Lee JS, Xing L, Cheng RH, Wang L, Lam KS.

Biomaterials. 2009 Oct;30(30):6006-16. doi: 10.1016/j.biomaterials.2009.07.015. Epub 2009 Aug 5.

7.

Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.

Zhan C, Gu B, Xie C, Li J, Liu Y, Lu W.

J Control Release. 2010 Apr 2;143(1):136-42. doi: 10.1016/j.jconrel.2009.12.020. Epub 2010 Jan 7.

PMID:
20056123
8.

Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.

He X, Li L, Su H, Zhou D, Song H, Wang L, Jiang X.

Int J Nanomedicine. 2015 Mar 5;10:1791-804. doi: 10.2147/IJN.S75186. eCollection 2015.

9.

Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.

Zhang L, Zhu D, Dong X, Sun H, Song C, Wang C, Kong D.

Int J Nanomedicine. 2015 Mar 16;10:2101-14. doi: 10.2147/IJN.S77667. eCollection 2015.

10.

Delivery of paclitaxel by physically loading onto poly(ethylene glycol) (PEG)-graft-carbon nanotubes for potent cancer therapeutics.

Lay CL, Liu HQ, Tan HR, Liu Y.

Nanotechnology. 2010 Feb 10;21(6):065101. doi: 10.1088/0957-4484/21/6/065101. Epub 2010 Jan 8.

PMID:
20057024
11.

Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors.

Bajaj G, Kim MR, Mohammed SI, Yeo Y.

J Control Release. 2012 Mar 28;158(3):386-92. doi: 10.1016/j.jconrel.2011.12.001. Epub 2011 Dec 9. Erratum in: J Control Release. 2012 Aug 20;162(1):257.

12.

Targeted delivery of platinum-taxane combination therapy in ovarian cancer.

Desale SS, Soni KS, Romanova S, Cohen SM, Bronich TK.

J Control Release. 2015 Dec 28;220(Pt B):651-9. doi: 10.1016/j.jconrel.2015.09.007. Epub 2015 Sep 14.

13.

Efficient inhibition of colorectal peritoneal carcinomatosis by drug loaded micelles in thermosensitive hydrogel composites.

Gong C, Wang C, Wang Y, Wu Q, Zhang D, Luo F, Qian Z.

Nanoscale. 2012 May 21;4(10):3095-104. doi: 10.1039/c2nr30278k. Epub 2012 Apr 25.

PMID:
22535210
15.

Tumor-targeted paclitaxel-loaded folate conjugated poly(ethylene glycol)-poly(L-lactide) microparticles produced by supercritical fluid technology.

Huang X, Zhang Y, Yin G, Pu X, Liao X, Huang Z, Chen X, Yao Y.

J Mater Sci Mater Med. 2015 Feb;26(2):95. doi: 10.1007/s10856-015-5447-x. Epub 2015 Feb 4.

PMID:
25649516
16.

Enhanced efficacy of local etoposide delivery by poly(ether-anhydride) particles against small cell lung cancer in vivo.

Tang BC, Fu J, Watkins DN, Hanes J.

Biomaterials. 2010 Jan;31(2):339-44. doi: 10.1016/j.biomaterials.2009.09.033. Epub 2009 Sep 30.

17.

Characterization, pharmacokinetics and disposition of novel nanoscale preparations of paclitaxel.

Wang C, Wang Y, Wang Y, Fan M, Luo F, Qian Z.

Int J Pharm. 2011 Jul 29;414(1-2):251-9. doi: 10.1016/j.ijpharm.2011.05.014. Epub 2011 May 10.

PMID:
21596124
18.
19.

Intraperitoneal chemotherapy of ovarian cancer by hydrogel depot of paclitaxel nanocrystals.

Sun B, Taha MS, Ramsey B, Torregrosa-Allen S, Elzey BD, Yeo Y.

J Control Release. 2016 Aug 10;235:91-8. doi: 10.1016/j.jconrel.2016.05.056. Epub 2016 May 26.

PMID:
27238443
20.

PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.

Chu B, Qu Y, Huang Y, Zhang L, Chen X, Long C, He Y, Ou C, Qian Z.

Int J Pharm. 2016 Mar 16;500(1-2):345-59. doi: 10.1016/j.ijpharm.2016.01.030. Epub 2016 Jan 18.

PMID:
26794876

Supplemental Content

Support Center